Emergent BioSolutions
$53.149876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$53.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.14 (2.19%) Today
$0.00 (0.00%) As of 4:02 PM EDT after-hours
Why Robinhood?
You can buy or sell EBS and other stocks, options, ETFs, and crypto commission-free!
About EBS
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. Read More Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.
Employees
1,705
Headquarters
Gaithersburg, Maryland
Founded
1998
Market Cap
2.68B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
850.10K
High Today
$53.42
Low Today
$52.23
Open Price
$52.23
Volume
793.33K
52 Week High
$73.89
52 Week Low
$39.11
Collections
Price Paid on Robinhood
3% Higher
Right Now
52 Week Low
$46.93
Average Price Paid
$51.66
52 Week High
$73.89
Analyst Ratings
75%
of 8 ratings
Buy
75%
Hold
25%
Sell
0%
EBS Earnings
-$0.13
$0.27
$0.67
$1.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Oct 31, After Hours